Filter
682
Text search:
controlled
substances
Featured
Recommendations
88
New Publications
144
Language
Document type
No document type
387
Guidelines
133
Studies & Reports
78
Manuals
49
Strategic & Response Plan
16
Training Material
13
Fact sheets
4
Situation Updates
2
Countries / Regions
India
30
Kenya
29
South Africa
22
Western and Central Europe
19
Global
17
Nigeria
15
Uganda
15
Ethiopia
12
Ghana
12
Sierra Leone
10
Nepal
10
Tanzania
8
Liberia
7
Indonesia
7
Myanmar / Burma
7
Zimbabwe
6
Rwanda
6
Namibia
6
Eswatini/ Swaziland
6
Zambia
5
Ukraine
5
Eastern Europe
5
Russia
5
USA
4
Syria
4
Malawi
4
Botswana
4
Lesotho
4
Africa
4
Guinea
3
Senegal
3
Philippines
3
Afghanistan
3
Germany
3
Bangladesh
3
South–East Asia Region
3
Latin America and the Carribbean
3
Burkina Faso
2
Congo, Democratic Republic of
2
South Sudan
2
Iraq
2
Lebanon
2
Cambodia
2
Thailand
2
Argentina
2
North Macedonia
2
Hungary
2
Yemen
2
Eastern Europe and Central Asia
2
Tajikistan
2
Kyrgyzstan
2
Mali
1
Morocco
1
Cameroon
1
Pakistan
1
Jordan
1
Mozambique
1
Papua New Guinea
1
Sudan
1
Brazil
1
Serbia
1
Colombia
1
Mexico
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Asia
1
Venezuela
1
Poland
1
Albania
1
Moldova
1
Iran
1
Australia
1
Kazakhstan
1
Georgia
1
Jamaica
1
United Kingdom
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
227
Clinical Guidelines
56
Public Health
30
Key Resources
27
Pharmacy & Technologies
22
Women & Child Health
21
Capacity Building
10
Toolboxes
Mental Health
137
Pharmacy
60
HIV
33
Caregiver
28
AMR
27
Rapid Response
26
COVID-19
26
TB
23
Planetary Health
20
Ebola
19
NCDs
19
Specific Hazards
14
Conflict
10
Global Health Education
7
Natural Hazards
5
Refugee
5
NTDs
5
Cholera
4
Disability
2
Polio
2
Social Ethics
2
WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses
This block contains a wide variety of disorders that differ in severity (from uncomplicated intoxication and harmful use to obvious psychotic disorders and dementia), but that are all attributable to the use of one or more psychoactive substances (w
...
World Drug Report 2018
-3-
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
World Drug Report 2018
-2-
Drug Advisory Board
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also re
...
Perspectives on Drugs
Therapeutics Information and Pharmacovigilance Centre | TIPC
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from
...
Volume 20, September
Global smart update
Maintaining proper storage conditions for health commodities is vital to ensuring their quality. Product expiration dates are based on ideal storage conditions and protecting product quality until their expiration date is important for serving customers and conserving resources. Guidelines for the S
...
Cognitive deficits in schizophrenia can massively impact functionality and quality of life, furthering the importance of cognitive training. Despite the development of the field in Europe and in the United States, no programmes have been developed and tested in developing countries. Different cultur
...
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid
...
SCOPING QUESTION:Which psychosocial interventions are effective in the treatment of psychostimulant dependence for adults and young people?
Legislative and Policy analysis and recommendations for reform
